Democratizing simulations in healthcare

InSilicoTrials works with Pharma and Medical Devices companies to create a secure cloud-based computational hub in an easy and cost effective way

What is InSilicoTrials?

Optimization of medical device development

Use simulations to design and safely test new products in virtual patients

Modeling for dose selection, special populations, drug interactions

Estimate the right dose for the patient profile of interest

Integrated framework from data to treatment

Digitalize, integrate and analyze multidisciplinary data, e.g. clinical, images, genetic, etc.

Collaborative cloud platform

Share data, generate models, run simulations and analyze results with your project team

Reporting by guidelines

Present your simulation results following regulatory guidelines recommendations

Trusted Partnership

Reach out to a team of specialists who can assist you to overcome project hurdles and commercialize assets

Our business workflow


Research Centers

Have you developed a model which you want to make ready-to-use to a larger audience? Commercialize it through our platform


Do you have data that you want to digitize and structure in an integrated platform? Do you plan analysis and data mining? Look for our solutions


Are data and models part of your assets? Do you want to host or commercialize them in a secure and protected environment? Reach out to us

Software solution providers

Are simulation and data analysis tools your core business? Have you considered expanding your customers base with on-demand offers? Provide your solutions through our platform

Maximize your assets!



We can help you achieve your goals using modeling and simulation tailored to customize your projects by leveraging scientific and technological advice.

Researchers & Clinicians

Are on-demand software and computing power what you need? Are you looking for an easy but sophisticated modeling and simulation tool? Answer your scientific questions through our platform.

Accelerate your project!

Why should I use it?

Develop and run your model
Easy access to models in Digital Library
Guaranteed data protection and cybersecurity
On-demand cloud computing
Ready-to-use computational environment
Option to report as by regulatory guidelines

Models and Simulations

QT/TdP Risk Screen

A new assessment tool for the preclinical screening of drug compounds. QT/TdP Risk Screen will help you to spot potential clinical drug-induced cardiac safety risks based on CredibleMeds classification and to identify safe concentration ranges for your compounds. Provided by Universitat Politècnica de València (UPV, Valencia) and Fundació Institut Mar D'Investigacions Mèdiques (FIMIM, Barcelona).


A new assessment tool for the preclinical screening of drug compounds. STrhiPS will help you to reconstruct the human ventricular action potential by means of in silico cellular studies performed on a population of human induced Pluripotent Stem Cell-Cardiomyocytes (hiPSC-CMs) to predict the proarrhythmic liability of your compounds. Provided by Bologna University (UniBo, Bologna) and Tampere University (TAU, Tampere).


Find out more about the interactions between implanted medical devices and the magnetic resonance imaging (MRI). With NuMRis - Numeric Magnetic Resonance implant testing, you will be able to simulate the behavior of the medical device (e.g. stent, hip prosthesis, 3D printed implant) during an MRI scan, to analyze the effects on the patient, and to quantify the dose and thermal outcomes due to the exposure.


CONSELF is a cloud platform designed to allows healthcare companies to perform computational fluid dynamic (CFD) and finite element model (FEM) analysis through a Software as a Service (SaaS) access in pay-per-use mode. Now you can analyze your ideas, maximize performance, estimate durability and safety, evaluate stresses and deformations and much more in a flexible and cost-effective way. The platform can be used both as a general-purpose simulation solver or through guided workflows to perform In Silico reproduction of standardized testing to evaluate design alternatives and identify worst-case scenarios before prototyping.

"As simulation is now recommended by regulatory authorities and policy makers to accelerate approval without compromising with patient safety, it is essential to make available advanced simulation tools like ANSYS to the largest possible audience, no matter of their engineering simulation background. InSilicoTrials.com is the platform bridging the gap between software providers and clinical consumers."
Thierry Marchal
Global Industry Director Healthcare at ANSYS
"FDA's efforts in modeling and simulation are enabled through multiple collaborations with external parties that provide additional expertise and infrastructure to advance the development of these state-of-the-art technologies." - July 7, 2017 by FDA Voice
Scott Gottlieb
Former Commissioner of the U.S. Food and Drug Administration (FDA)
"QT/TdP Risk Screen is in line with current initiatives aiming to define a new paradigm in cardiac safety like comprehensive in vitro proarrhythmia assay (CiPA), where modeling and simulation of the human cellular ventricular electrophysiology plays a relevant role in the assessment of the proarrhythmic risk of drugs."
Javier Saiz
Full Professor at Universitat Politècnica de València (UPV, Valencia)

Our network